Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
2 other identifiers
interventional
79
1 country
1
Brief Summary
Background: Researchers use mixed meal tolerance tests (MMTTs) to look at how people s bodies respond to eating a meal. However, researchers do not agree on how to decide the number of calories to give in each meal. Some use fixed meals, which are the same size for everyone, and some use adjusted meals, based on the size of the person s body. Researchers want to know which MMTT is best to use for future research. Objective: To learn how fixed vs adjusted meals affect blood glucose levels in healthy people. Eligibility: Healthy people aged 18 years or older. Design: Participants will have 3 or 4 clinic visits of up to 8 hours in 8 weeks. Participants will have baseline tests: Their height, weight, and waist size will be measured. They will have an oral glucose tolerance test: A needle attached to a tube (IV) will be inserted into a vein in the arm. They will have a sugary drink. Blood samples will be taken from the tube at intervals up to 3 hours after the drink. They will have a body scan. Participants will have 2 MMTT visits. One will include a fixed meal and one will include an adjusted meal. They will have tests at both visits: Resting metabolic rate: A clear hood will be placed over the participant s head while they rest for 20 minutes. This will measure the oxygen they breathe in and out. MMTT. Participants will have 5 minutes to drink a liquid meal. Blood samples will be taken at intervals for the next 4 hours....
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Aug 2024
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2024
CompletedFirst Posted
Study publicly available on registry
January 25, 2024
CompletedStudy Start
First participant enrolled
August 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 12, 2026
June 10, 2026
2.9 years
January 24, 2024
June 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine whether an adjusted energy dose MMTTor a fixed dosed meal will result in greater variability in glucose area under the curve (AUC) within the same participants across a range of BMIs.
Glucose AUC associated with MMTT conditions (fixed vs. adjusted).
Baseline, Visit 3/4
Secondary Outcomes (3)
Body Composition
Baseline, Visit 3/4
Resting Metabolic Rate
Baseline, Visit 3/4
Lipids
Baseline, Visit 3/4
Study Arms (2)
1
ACTIVE COMPARATORFixed Mixed Meal Test
2
ACTIVE COMPARATORAdjusted Mixed Meal Test
Interventions
a body weight ADJUSTED dose liquid meal. (30% of total daily energy requirements)
Eligibility Criteria
You may qualify if:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provision of signed and dated informed consent form.
- Agreement to adhere to Lifestyle Considerations throughout study duration.
- Males and females; Age \>= 18years
- Healthy, as determined by medical history, physical examination, and laboratory tests.
You may not qualify if:
- An individual who meets any of the following criteria will be excluded from participation in this
- study:
- Current use of medications, dietary supplements, or alternative therapies known to alter energy metabolism.
- Fasting plasma glucose \>= 126 mg/dL
- Type I or Type II Diabetes Mellitus by self-report.
- Hematologic disorders including significant anemia (male hemoglobin \< 13.0 g/dL or female hemoglobin \< 11.0 g/dL)
- Current pregnancy, pregnancy within the past 6 months or currently lactating
- History or self-report of gastrointestinal disease, including inflammatory bowel diseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes (e.g. celiac disease), gastric ulcer (active) which may alter metabolism or absorption of study food by self-report
- Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumption screening AUDIT questionnaire in adults.
- Participants who report taking large doses of acetaminophen (\> 3 grams daily) who cannot stop acetaminophen 24 hours prior to and following the meal tests will be excluded from the study.
- Inability to consume provided food based on a food allergy or intolerance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NIDDK, Phoenix
Phoenix, Arizona, 85014, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susanne M Votruba, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2024
First Posted
January 25, 2024
Study Start
August 23, 2024
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
June 12, 2026
Record last verified: 2026-06-10
Data Sharing
- IPD Sharing
- Will not share